advanced search

Welcome: Guest

log in

Republic of Korea Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Publication Date November 2008
Publisher Global Markets Direct
Product Type Report
Pages 80
ISBN Number not applicable
Product Code GMD07662
Price

£1,960.00
approximately: $2,997 | €2,186

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

Republic of Korea Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for indepth information and data relating to the Republic of Korea ophthalmic devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key subsegments of the ophthalmic devices in Republic of Korea

Scope

  • The report provides ophthalmic devices information broken down into detailed categories and segments in Republic of Korea.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the ophthalmic devices market in Republic of Korea.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

  • 1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Ophthalmic Devices
    • 3.2 Cataract Surgery
      • 3.2.1 Phacoemulsification Equipment
      • 3.2.2 Intra Ocular Lens
    • 3.3 Vision Care
      • 3.3.1 Ophthalmoscopes
      • 3.3.2 Contact lenses
      • 3.3.3 Lens care
      • 3.3.4 Ophthalmic lens
      • 3.3.5 Rigid Gas Permeable Contact Lenses
    • 3.4 Refractive Surgery
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Premarket Notification for Class I Devices
      • 5.1.3 Premarket Approval for Class II, III and IV Devices
        • 5.1.3.1 Technical Review:
        • 5.1.3.2 Type Testing:
        • 5.1.3.3 Applying for Product License:
        • 5.1.3.4 KGMP Certification
      • 5.1.4 License Fee
      • 5.1.5 License Application Processing Duration
    • 5.2 Postmarket Surveillance
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 Ophthalmic Devices In Republic of Korea
    • 8.1 Ophthalmic Devices Cross Country Comparison (20002012)
    • 8.2 Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), 20002012
    • 8.3 Ophthalmic Devices, Republic of Korea, Category Volume (Units), 20002012
    • 8.4 Ophthalmic Devices, Republic of Korea Company share (20062007)
  • 9 Cataract Surgery In Republic of Korea
    • 9.1 Cataract Surgery Overall Revenue (20002012)
    • 9.2 Cataract Surgery Overall Volume (20002012)
    • 9.3 Cataract Surgery Average Price (20002012)
    • 9.4 Cataract Surgery Distribution Share (20062007)
    • 9.5 Cataract Surgery, Republic of Korea, Company Share (20062007)
  • 10 Refractive Surgery In Republic of Korea
    • 10.1 Refractive Surgery Overall Revenue (20002012)
    • 10.2 Refractive Surgery Overall Volume (20002012)
    • 10.3 Refractive Surgery Average Price (20002012)
    • 10.4 Refractive Surgery Distribution Share (20062007)
    • 10.5 Refractive Surgery, Republic of Korea, Company Share (20062007)
  • 11 Vision Care In Republic of Korea
    • 11.1 Vision Care Overall Revenue (20002012)
    • 11.2 Vision Care Overall Volume (20002012)
    • 11.3 Vision Care Average Price (20002012)
    • 11.4 Vision Care Distribution Share (20062007)
    • 11.5 Vision Care, Republic of Korea, Company Share (20062007)
  • 12 Alcon, Inc. Company Profile
    • 12.1 Company Overview
    • 12.2 Value Chain Analysis
      • 12.2.1 Manufacturing
        • 12.2.1.1 In House Manufacturing
        • 12.2.1.2 Outsourcing
      • 12.2.2 Product Development
        • 12.2.2.1 Research and Development
        • 12.2.2.2 Regulatory Approvals
        • 12.2.2.3 Clinical Trials
      • 12.2.3 Sales and Marketing
        • 12.2.3.1 Licensing Agreements
        • 12.2.3.2 Partnerships and Alliances
      • 12.2.4 Alcon, Inc. Pipeline Products by Equipment Type
      • 12.2.5 Alcon, Inc. Pipeline Products by Development Type
      • 12.2.6 Alcon, Inc. Pipeline Products by Therapy Area
      • 12.2.7 Alcon, Inc. Pipeline Products by Clinical Trials
      • 12.2.8 Alcon, Inc. Pipeline Products by News Summary
  • 13 Advanced Medical Optics, Inc. Company Profile
    • 13.1 Company Overview
    • 13.2 Value Chain Analysis
      • 13.2.1 Manufacturing
        • 13.2.1.1 In House Manufacturing
      • 13.2.2 Product Development
        • 13.2.2.1 Research and Development
        • 13.2.2.2 Regulatory Approvals
        • 13.2.2.3 Clinical Trials
      • 13.2.3 Sales and Marketing
        • 13.2.3.1 Partnerships and Alliances
      • 13.2.4 Advanced Medical Optics, Inc. Pipeline Products by Equipment Type
      • 13.2.5 Advanced Medical Optics, Inc. Pipeline Products by Development Type
      • 13.2.6 Advanced Medical Optics, Inc. Pipeline Products by Therapy Area
      • 13.2.7 Advanced Medical Optics, Inc. Pipeline Products by Clinical Trials
  • 14 Bausch & Lomb Incorporated Company Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
        • 14.2.1.1 In House Manufacturing
        • 14.2.1.2 Outsourcing
      • 14.2.2 Product Development
        • 14.2.2.1 Clinical Trials
        • 14.2.2.2 Regulatory Approvals
        • 14.2.2.3 Research and Development
      • 14.2.3 Sales and Marketing
        • 14.2.3.1 Edistribution
        • 14.2.3.2 Partnerships and Alliances
        • 14.2.3.3 Licensing Agreements
    • 14.3 Bausch & Lomb Incorporated Pipeline Products
      • 14.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type
      • 14.3.2 Bausch & Lomb Incorporated Pipeline Products by Development Type
      • 14.3.3 Bausch & Lomb Incorporated Pipeline Products by Therapy Area
      • 14.3.4 Bausch & Lomb Incorporated Pipeline Products by Clinical Trials
      • 14.3.5 By News Summary
  • 15 Johnson & Johnson Vision Care, Inc. Company Profile
    • 15.1 Company Overview
  • 16 Essilor International Company Profile
    • 16.1 Company Overview
    • 16.2 Value Chain Analysis
      • 16.2.1 Manufacturing
        • 16.2.1.1 In House Manufacturing
      • 16.2.2 Product Development
        • 16.2.2.1 Regulatory Approvals
        • 16.2.2.2 Research and Development
      • 16.2.3 Sales and Marketing
        • 16.2.3.1 Partnerships and Alliances
  • 17 Carl Zeiss AG Company Profile
    • 17.1 Company Overview
    • 17.2 Value Chain Analysis
      • 17.2.1 Manufacturing
        • 17.2.1.1 In House Manufacturing
        • 17.2.1.2 Outsourcing
      • 17.2.2 Product Development
        • 17.2.2.1 Regulatory Approvals
        • 17.2.2.2 Clinical Trials
        • 17.2.2.3 Research and Development
      • 17.2.3 Sales and Marketing
        • 17.2.3.1 Partnerships and Alliances
        • 17.2.3.2 Licensing Agreements
    • 18.1 Global Markets Direct Research Methodology
    • 18.2 Coverage
    • 18.3 Secondary Research
    • 18.4 Primary Research
    • 18.5 Models
    • 18.6 Forecasts
    • 18.7 Expert Panels
    • 18.8 Currency Conversion
    • 18.9 Contact Us
    • 18.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Hospital Wards by Specialty in Republic of Korea, 20032007
    • Table 2: Doctors by Specialty in Republic of Korea, 20032007
    • Table 3: Healthcare Institutions in Republic of Korea, 20012005
    • Table 4: Healthcare Personnel in Republic of Korea, 19752002
    • Table 5: Classification of Medical Equipment in Republic of Korea
    • Table 6: Ophthalmic Devices Cross Country Comparison (20002012)
    • Table 7: Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), 20002012
    • Table 8: Ophthalmic Devices Market, Republic of Korea , Portfolio Analysis, 20002012
    • Table 9: Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 20002007
    • Table 10: Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 20072012
    • Table 11: Ophthalmic Devices, Republic of Korea, Category Volume (Units), 20002012
    • Table 12: Ophthalmic Devices, Republic of Korea, Category Volume (Units), Historic, 20002007
    • Table 13: Ophthalmic Devices, Republic of Korea, Category Volume (Units), Forecast, 20072012
    • Table 14: Ophthalmic Devices, Republic of Korea Company share by Revenue ($ mn), 20062007
    • Table 15: Cataract Surgery, Republic of Korea, Revenue ($ mn) by Segment, Historic, 20002007
    • Table 16: Cataract Surgery, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 20072012
    • Table 17: Cataract Surgery, Republic of Korea, Overall Volume (Units), Historic, 20002007
    • Table 18: Cataract Surgery, Republic of Korea, Overall Volume (Units), Forecast, 20072012
    • Table 19: Cataract Surgery, Republic of Korea, Average Price ($), Historic, 20002007
    • Table 20: Cataract Surgery, Republic of Korea, Average Price ($), Forecast, 20072012
    • Table 21: Cataract Surgery, Republic of Korea, Distribution Share by Revenue ($mn), 20062007
    • Table 22: Cataract Surgery, Republic of Korea, Company Share by Revenue ($ mn), 20062007
    • Table 23: Refractive Surgery, Republic of Korea, Revenue ($ mn), Historic, 20002007
    • Table 24: Refractive Surgery, Republic of Korea, Revenue ($ mn), Forecast, 20072012
    • Table 25: Refractive Surgery, Republic of Korea, Overall Volume (Units), Historic, 20002007
    • Table 26: Refractive Surgery, Republic of Korea, Overall Volume (Units), Forecast, 20072012
    • Table 27: Refractive Surgery, Republic of Korea, Average Price ($), Historic, 20002007
    • Table 28: Refractive Surgery, Republic of Korea, Average Price ($), Forecast, 20072012
    • Table 29: Refractive Surgery, Republic of Korea, Distribution Share by Revenue ($mn), 20062007
    • Table 30: Refractive Surgery, Republic of Korea, Company Share by Revenue ($ mn), 20062007
    • Table 31: Vision Care, Republic of Korea, Revenue ($ mn) by Segment, Historic, 20002007
    • Table 32: Vision Care, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 20072012
    • Table 33: Vision Care, Republic of Korea, Overall Volume (Units), Historic, 20002007
    • Table 34: Vision Care, Republic of Korea, Overall Volume (Units), Forecast, 20072012
    • Table 35: Vision Care, Republic of Korea, Average Price ($), Historic, 20002007
    • Table 36: Vision Care, Republic of Korea, Average Price ($), Forecast, 20072012
    • Table 37: Vision Care, Republic of Korea, Distribution Share by Revenue ($mn), 20062007
    • Table 38: Vision Care, Republic of Korea, Company Share by Revenue ($ mn), 20062007
    • Table 39: Alcon, Inc. Pipeline Products by Equipment Type
    • Table 40 Alcon, Inc. Pipeline Products By Development Stage
    • Table 41: Alcon, Inc. Pipeline Products By Therapy Area
    • Table 42: Alcon, Inc. Pipeline Products By Clinical Trials
    • Table 43: Alcon, Inc. Pipeline Products By News Summaries
    • Table 44: Advanced Medical Optics, Inc. Pipeline Products by Equipment Type
    • Table 45: Advanced Medical Optics, Inc. Pipeline Products By Development Stage
    • Table 46: Advanced Medical Optics, Inc. Pipeline Products By Therapy Area
    • Table 47: Advanced Medical Optics, Inc. Pipeline Products By Clinical Trials
    • Table 48: Table 49: Bausch & Lomb Incorporated Pipeline Products by Equipment Type
    • Table 48: Bausch & Lomb Incorporated Pipeline Products By Development Stage
    • Table 50: Bausch & Lomb Incorporated Pipeline Products By Therapy Area
    • Table 51: Bausch & Lomb Incoarporated Pipeline Products By Clinical Trials
    • Table 52: Bausch & Lomb Incorporated Pipeline Products By News Summaries
    • Table 53: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • 1.2 List of Figures
    • Figure 1: Healthcare Financing in Republic of Korea, 2007
    • Figure 2: Healthcare Expenditure in Republic of Korea, 2000 2006
    • Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007
    • Figure 4: Medical Device Pricing System in Republic of Korea, 2007
    • Figure 5: Ophthalmic Devices Cross Country Comparison (20002012)
    • Figure 6: Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), 20002012
    • Figure 7: Ophthalmic Devices Market, Republic of Korea , Portfolio Analysis, 20002012
    • Figure 8: Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 20002007
    • Figure 9: Ophthalmic Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 20072012
    • Figure 10: Ophthalmic Devices, Republic of Korea Company share (%), 2007
    • Figure 11: Cataract Surgery, Republic of Korea, Revenue ($ mn) by Segment, Historic, 20002007
    • Figure 12: Cataract Surgery, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 20072012
    • Figure 13: Cataract Surgery, Republic of Korea, Overall Volume (Units), Historic, 20002007
    • Figure 14: Cataract Surgery, Republic of Korea, Overall Volume (Units), Forecast, 20072012
    • Figure 15: Cataract Surgery, Republic of Korea, Company Share (%), 2007
    • Figure 16: Refractive Surgery, Republic of Korea, Revenue ($ mn), Historic, 20002007
    • Figure 17: Refractive Surgery, Republic of Korea, Revenue ($ mn), Forecast, 20072012
    • Figure 18: Refractive Surgery, Republic of Korea, Overall Volume (Units), Historic, 20002007
    • Figure 19: Refractive Surgery, Republic of Korea, Overall Volume (Units), Forecast, 20072012
    • Figure 20: Refractive Surgery, Republic of Korea, Company Share (%), 2007
    • Figure 21: Vision Care, Republic of Korea, Revenue ($ mn) by Segment, Historic, 20002007
    • Figure 22: Vision Care, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 20072012
    • Figure 23: Vision Care, Republic of Korea, Overall Volume (Units), Historic, 20002007
    • Figure 24: Vision Care, Republic of Korea, Overall Volume (Units), Forecast, 20072012
    • Figure 25: Vision Care, Republic of Korea, Company Share (%), 2007
    • Figure 26: Alcon, Inc. Value Chain Analysis
    • Figure 27: Advanced Medical Optics, Inc. Value Chain Analysis
    • Figure 28: Bausch & Lomb Incorporated Value Chain Analysis
    • Figure 29: Essilor International Value Chain Analysis
    • Figure 30: Carl Zeiss AG Value Chain Analysis
    • Figure 31: Global Markets Direct Methodology